UCB.BR - UCB S.A.
NEXT EARNINGS:
Feb 26, 2026
(in 2 days)
EPS Est: $5.10
|
Rev Est: $4.2B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
Market Cap:
51.47B
Volume:
222,821
Avg Volume:
195,855
52 Week Range:
129.35-289.5
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.27
Last Dividend:
$1.39
Exchange:
BRU
Country:
BE
Employees:
9,052
IPO Date:
2000-01-04
EPS (TTM):
5.61
P/E Ratio:
34.27
Revenue (TTM):
6.15B
Total Assets:
17.35B
Total Debt:
3.03B
Cash & Equiv:
1.57B
Rev Growth (5Y):
4.6%
EPS Growth (5Y):
5.8%
FCF Growth (5Y):
11.7%
ROCE:
9.6%
Debt/Equity:
0.30
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-07-31 | $3.59 | $3.36 | +6.8% | $3.5B | $3.3B | +6.9% |
| 2025-02-27 | $2.85 | $2.58 | +10.5% | $3.4B | $3.1B | +9.8% |
| 2024-07-25 | $2.06 | $1.74 | +18.4% | $2.8B | $2.6B | +5.9% |
| 2024-04-25 | $1.58 | $1.36 | +16.2% | $2.7B | $2.6B | +3.0% |
| 2023-07-27 | $1.60 | $1.69 | -5.3% | $2.6B | $2.5B | +2.0% |
| 2023-02-22 | $0.10 | $0.76 | -86.9% | $2.6B | $5.3B | -50.7% |
| 2022-06-30 | $2.05 | $2.45 | -16.3% | $2.9B | $2.7B | +7.6% |
| 2021-12-31 | $2.51 | $2.64 | -4.9% | $3.0B | $2.8B | +5.3% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.15B | 5.25B | 5.52B | 5.78B | 5.35B | 4.91B | 4.63B | 4.47B | 4.15B | 3.88B | 3.34B | 3.13B |
| Net Income | 1.06B | 343.00M | 418.00M | 1.06B | 732.00M | 792.00M | 800.00M | 753.00M | 520.00M | 264.00M | 115.00M | 82.00M |
| EPS | 5.61 | 1.81 | 2.20 | 5.60 | 3.87 | 4.23 | 4.24 | 3.99 | 2.88 | 1.37 | 0.60 | 0.45 |
| Total Assets | 17.35B | 15.54B | 15.87B | 14.21B | 13.32B | 11.08B | 10.51B | 9.92B | 10.21B | 10.96B | 10.15B | 9.76B |
| Total Debt | 3.03B | 3.04B | 2.90B | 2.12B | 2.75B | 1.28B | 1.50B | 1.57B | 1.60B | 2.50B | 2.12B | 2.75B |
| Cash & Equivalents | 1.57B | 861.00M | 899.00M | 1.26B | 662.00M | 329.00M | 1.26B | 1.05B | 761.00M | 1.28B | 507.00M | 750.00M |
| Operating Cash Flow | 1.24B | 761.00M | 1.04B | 1.49B | 1.01B | 823.00M | 1.09B | 927.00M | 427.00M | 246.00M | 552.00M | 288.00M |
| Free Cash Flow | 920.00M | 445.00M | 674.00M | 997.00M | 662.00M | 529.00M | 995.00M | 827.00M | 319.00M | 175.00M | 468.00M | 50.00M |
| FCF per Share | 4.84 | 2.35 | 3.55 | 5.28 | 3.50 | 2.83 | 5.28 | 4.39 | 1.69 | 0.91 | 2.46 | 0.27 |
| Book Value | 10.03B | 8.97B | 9.06B | 8.39B | 7.27B | 7.04B | 6.31B | 5.81B | 5.58B | 5.67B | 5.00B | 4.45B |
| Cash & ST Investments | 1.76B | 923.00M | 1.07B | 1.37B | 1.37B | 1.32B | 1.28B | 1.06B | 761.00M | 1.28B | 508.00M | 751.00M |
| ROC Equity | 0.11 | 0.04 | 0.05 | 0.13 | 0.10 | 0.11 | 0.13 | 0.13 | 0.09 | 0.05 | 0.02 | 0.02 |